From: Heart failure therapy in diabetic patients-comparison with the recent ESC/EASD guideline
No Diabetes (n = 2310) | Diabetes (n = 994) | P value for respective effect | ||||
---|---|---|---|---|---|---|
DM | EF | |||||
EF <50% (n = 1769) | EF ≥ 50% (n = 541) | EF <50% (n = 824) | EF ≥ 50% (n = 170) | |||
Female (%) | 23.5 | 49.2 | 28.9 | 51.2 | 0.005 | <0.001 |
Age (years) | 61.1 ± 14.3 | 63.1 ± 14.0 | 67.2 ± 10.3 | 69.4 ± 7.6 | <0.001 | <0.001 |
Body mass index (kg/m2) | 26.9 ± 4.5 | 28.5 ± 5.1 | 29.1 ± 5.5 | 30.3 ± 5.3 | <0.001 | <0.001 |
Heart rate (bpm) | 73.0 ± 13.5 | 69.7 ± 12.7 | 74.2 ± 12.5 | 72.4 ± 14.4 | 0.004 | <0.001 |
Systolic blood pressure (mmHg) | 121 ± 19 | 138 ± 23 | 125 ± 19 | 140 ± 21 | <0.001 | <0.001 |
Diastolic blood pressure (mmHg) | 73 ± 11 | 79 ± 12 | 73 ± 11 | 77 ± 13 | 0.076 | <0.001 |
Glomerular filtration rate (mL/min) | 72 ± 24 | 75 ± 22 | 64 ± 26 | 68 ± 24 | <0.001 | 0.002 |
Hb (mmol/mL) | 8.7 ± 1.1 | 8.7 ± 1.0 | 8.4 ± 1.2 | 8.3 ± 1.1 | <0.001 | 0.644 |
SF-36 score | 52 ± 28 | 59 ± 28 | 44 ± 28 | 44 ± 27 | <0.001 | 0.020* |